THE Medicines and Healthcare products Regulatory Agency has launched a consultation on how best to engage and involve patients and the public. The responses will help to inform MHRA’s future engagement with them.
MHRA wants to adopt a more systematic approach to listening to and involving patients. They want to make sure that the patient voice is more clearly heard when safety issues, concerning medicines or medical devices, are identified and in the licensing of new medicines.
The consultation will additionally look at how patients and the public would like MHRA to communicate with them. It will also look at how patients and the public would like to communicate with the MHRA to raise concerns and how MHRA can best respond.
MHRA would like to hear from patients, patient group representatives as well as healthcare professionals. The link to the consultation is here and it closes on Monday 7 October.
© Institute of Physics and Engineering in Medicine
Registered in England and Wales (No. 3080332)
Registered Charity (No.1047999)